澳门新葡亰平台游戏app|官网-2019超火爆

ME学术大讲堂第一百八十五讲:Topology Optimization for Coronary Stents with Auxetic Metamaterials
来源:机械工程学院 发布日期:2019-11-18 浏览次数:86
分享到:

一、时间

        2019年11月19日星期二,15:30-17:30


二、地点

        机械楼 D526


三、主讲人

        罗震 教授 悉尼科技大学


四、报告人简介

        Dr Zhen Luo is currently an associate professor at University of Technology Sydney (UTS), and the Director for the university research center "Advanced Computational Design and Manufacturing". He received his PhD degree from Mechanical Engineering, HUST in 2005. After that, he worked as a research fellow at Chinese University of Hong Kong, University of Sydney, and University of New South Wales for 7 years. His research focuses on topological optimization, design optimization with sampling and surrogate models, uncertainty analysis-driven reliability and robust design optimization, metamaterials, cellular/lattice composites, and multiscale modelling and design, as well as his recent interest in additive manufacturing for complex geometries. Zhen is the author for over 100 peer-reviewed journal papers, including 89 JCR-Q1 journal papers. His Scopus citations are around 3000 times and Scopus h-index is 32. Dr Luo has received several competitive and industrial research grants, including ARC DP (Australian Research Council, Discovery Project), NSFC (National Natural Science Foundation of China) and AutoCRC (Australian Cooperative Research Centre for Advanced Automotive Technology). He has editorial roles for several international journals, including Structural and Multidisciplinary Optimization. He has been the supervisor for 11 PhD students, with 8 successful completions.


五、报告内容

        Coronary artery disease (CAD) is currently one of the major causes of human death globally. Today stents are the most important implantation devices for Percutaneous Coronary Intervention (PCI) procedures. This seminar focuses on a systematic design method to generate novel stenting structural architectures, by using topological design optimization and auxetic metamaterials. New stenting structure will be expected to enhance the efficacy and safety of stents, finally benefit clinic outcomes.